PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ABT-737. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

30 hits

Retracted publication 2021-03-31

ABT‑737, a Bcl‑2 family inhibitor, has a synergistic effect with apoptosis by inducing urothelial carcinoma cell necroptosis.

Cheng R, Liu X, Wang Z, Tang K.

Mol Med Rep · retracted publication; research-article; journal article · DOI 10.3892/mmr.2021.12051

Bibliografisk träff 2021-03-31

Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis.

Mizutani N, Hikita H, Saito Y, Myojin Y, Sato K, Urabe M, Kurahashi T, Shiode Y, Sakane S, Murai K, Nozaki Y, Kodama T, Sakamori R, Yoshida Y, Tatsumi T, Takehara T.

Am J Physiol Gastrointest Liver Physiol · research support, non-u.s. gov't; journal article · DOI 10.1152/ajpgi.00370.2020

Bibliografisk träff 2021-02-01

Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2.

Nguyen W, Lee EF, Evangelista M, Lee M, Harris TJ, Colman PM, Smith NA, Williams LB, Jarman KE, Lowes KN, Haeberli C, Keiser J, Smith BJ, Fairlie WD, Sleebs BE.

ACS Infect Dis · research support, non-u.s. gov't; journal article · DOI 10.1021/acsinfecdis.0c00700

Bibliografisk träff 2020-12-30

BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance.

Quezada MJ, Picco ME, Villanueva MB, Castro MV, Barbero G, Fernández NB, Illescas E, Lopez-Bergami P.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers13010078

Bibliografisk träff 2020-11-18

Melatonin Can Modulate the Effect of Navitoclax (ABT-737) in HL-60 Cells.

Lomovsky A, Baburina Y, Odinokova I, Kobyakova M, Evstratova Y, Sotnikova L, Krestinin R, Krestinina O.

Antioxidants (Basel) · research-article; journal article · DOI 10.3390/antiox9111143

Bibliografisk träff 2020-11-03

Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces <sup>18</sup>F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis.

Buschner G, Feuerecker B, Spinner S, Seidl C, Essler M.

Leuk Lymphoma · research support, non-u.s. gov't; journal article · DOI 10.1080/10428194.2020.1839648

Bibliografisk träff 2020-10-01

Mapping chemotherapeutic drug distribution in cancer cell spheroids using 2D-TOF-SIMS and LESA-TIMS-MS.

Cintron-Diaz YL, Acanda de la Rocha AM, Castellanos A, Chambers JM, Fernandez-Lima F.

Analyst · journal article · DOI 10.1039/c9an02245g

Bibliografisk träff 2020-08-18

Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma.

Liu M, Tu J, Feng Y, Zhang J, Wu J.

J Nanobiotechnology · brief-report; journal article · DOI 10.1186/s12951-020-00677-4

Bibliografisk träff 2020-08-12

The BCL-2 family protein inhibitor ABT-737 as an additional tool for the treatment of EBV-associated post-transplant lymphoproliferative disorders.

Robert A, Pujals A, Favre L, Debernardi J, Wiels J.

Mol Oncol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1002/1878-0261.12759

Bibliografisk träff 2020-06-22

An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells.

Masilamani AP, Dettmer-Monaco V, Monaco G, Cathomen T, Kuckuck I, Schultze-Seemann S, Huber N, Wolf P.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers12061648

Bibliografisk träff 2020-05-26

Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.

Dong D, Dong Y, Fu J, Lu S, Yuan C, Xia M, Sun L.

Life Sci · journal article · DOI 10.1016/j.lfs.2020.117846

Bibliografisk träff 2020-05-18

Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.

Florent R, Weiswald LB, Lambert B, Brotin E, Abeilard E, Louis MH, Babin G, Poulain L, N'Diaye M.

Cell Death Dis · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41419-020-2588-8

Bibliografisk träff 2020-03-05

The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice.

Ritschka B, Knauer-Meyer T, Gonçalves DS, Mas A, Plassat JL, Durik M, Jacobs H, Pedone E, Di Vicino U, Cosma MP, Keyes WM.

Genes Dev · research support, non-u.s. gov't; research-article; journal article · DOI 10.1101/gad.332643.119

Bibliografisk träff 2020-03-01

Gene Therapy with MiRNA-Mediated Targeting of Mcl-1 Promotes the Sensitivity of Non-Small Cell Lung Cancer Cells to Treatment with ABT-737.

Shahverdi M, Amini R, Amri J, Karami H.

Asian Pac J Cancer Prev · research-article; journal article · DOI 10.31557/apjcp.2020.21.3.675

Bibliografisk träff 2020-02-26

Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.

Valcourt DM, Dang MN, Scully MA, Day ES.

ACS Nano · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/acsnano.9b09263

Bibliografisk träff 2020-02-21

Comparison of putative BH3 mimetics AT-101, HA14-1, sabutoclax and TW-37 with ABT-737 in platelets.

Wei H, Harper MT.

Platelets · journal article · DOI 10.1080/09537104.2020.1724276

Bibliografisk träff 2019-12-31

The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death.

Hsin IL, Chou YH, Hung WL, Ko JL, Wang PH.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers12010108

Bibliografisk träff 2019-09-19

A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML.

Wang Q, Hao S.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2019.10891

Bibliografisk träff 2019-09-07

ABT-737 Triggers Caspase-Dependent Inhibition of Platelet Procoagulant Extracellular Vesicle Release during Apoptosis and Secondary Necrosis In Vitro.

Wei H, Harper MT.

Thromb Haemost · research-article; journal article · DOI 10.1055/s-0039-1693694

Bibliografisk träff 2019-08-16

Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells.

Shen HP, Wu WJ, Ko JL, Wu TF, Yang SF, Wu CH, Yeh CM, Wang PH.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2019.10755

Bibliografisk träff 2019-04-01

ABT-737 and erufosine combination against castration-resistant prostate cancer: a promising but cell-type specific response associated with the modulation of anti-apoptotic signaling.

Avsar Abdik E, Kaleagasioglu F, Abdik H, Sahin F, Berger MR.

Anticancer Drugs · research support, non-u.s. gov't; journal article · DOI 10.1097/cad.0000000000000736

Bibliografisk träff 2019-02-03

Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax).

Lever JR, Fergason-Cantrell EA.

Pharmacol Res · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1016/j.phrs.2019.01.040

Bibliografisk träff 2019-01-09

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.

Yu X, Dobrikov M, Keir ST, Gromeier M, Pastan IH, Reisfeld R, Bigner DD, Chandramohan V.

PLoS One · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0210608

Bibliografisk träff 2018-10-30

Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis.

Remy J, Linder B, Weirauch U, Konovalova J, Marschalek R, Aigner A, Kögel D.

Biochim Biophys Acta Mol Cell Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbamcr.2018.10.017

Bibliografisk träff 2018-10-25

ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line.

Hwang E, Hwang SH, Kim J, Park JH, Oh S, Kim YA, Hwang KT.

Ann Surg Treat Res · research-article; journal article · DOI 10.4174/astr.2018.95.5.240

Bibliografisk träff 2018-05-30

Anti-allergic and anti-inflammatory effects of the Bcl-2 inhibitor ABT-737 on experimental allergic rhinitis models.

Kim HY, Jeong HJ, Kim HM.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2018.05.044

Bibliografisk träff 2018-05-24

Aspirin restores ABT-737-mediated apoptosis in human renal carcinoma cells.

Ou YC, Li JR, Wang JD, Chen WY, Kuan YH, Yang CP, Liao SL, Lu HC, Chen CJ.

Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbrc.2018.05.142

Bibliografisk träff 2018-03-15

Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.

Zhang E, Yin S, Lu X, Ye L, Fan L, Hu H.

Nutrients · research-article; journal article · DOI 10.3390/nu10030353

Bibliografisk träff 2016-02-15

Comparison of in vitro antileukemic activity of obatoclax and ABT-737.

Opydo-Chanek M, Mazur L.

Tumour Biol · comparative study; research-article; journal article · DOI 10.1007/s13277-016-4943-z

Bibliografisk träff 2007-06-15

Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family.

Lee EF, Czabotar PE, Smith BJ, Deshayes K, Zobel K, Colman PM, Fairlie WD.

Cell Death Differ · letter · DOI 10.1038/sj.cdd.4402178